Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1997 1
2001 1
2002 19
2003 16
2004 25
2005 14
2006 15
2007 19
2008 15
2009 9
2010 9
2011 12
2012 12
2013 13
2014 5
2015 8
2016 7
2017 2
2018 5
2019 1
2020 4
2021 2
2023 1
2024 1

Text availability

Article attribute

Article type

Publication date

Search Results

203 results

Results by year

Filters applied: . Clear all
Page 1
Immunotherapy for Cancer: Something Old, Something New.
Filippi L, Brechbiel MW. Filippi L, et al. Among authors: brechbiel mw. Cancer Biother Radiopharm. 2023 May;38(4):209-210. doi: 10.1089/cbr.2022.29014.editorial. Epub 2023 Feb 21. Cancer Biother Radiopharm. 2023. PMID: 36809052 No abstract available.
Introduction.
Brechbiel MW. Brechbiel MW. Cancer Biother Radiopharm. 2021 Aug;36(6):447. doi: 10.1089/cbr.2021.29009.mwb. Cancer Biother Radiopharm. 2021. PMID: 34314616 No abstract available.
Reply to the 'Comment on "Investigation of Zr(iv) and 89Zr(iv) complexation with hydroxamates: progress towards designing a better chelator than desferrioxamine B for immuno-PET imaging"' by A. Bianchi and M. Savastano, Chem. Commun., 2020, 56, D0CC01189D.
Guérard F, Lee YS, Tripier R, Szajek LP, Deschamps JR, Brechbiel MW. Guérard F, et al. Among authors: brechbiel mw. Chem Commun (Camb). 2020 Oct 25;56(83):12667-12668. doi: 10.1039/d0cc03594g. Epub 2020 Sep 18. Chem Commun (Camb). 2020. PMID: 32944719 Free article.
Targeted α-Therapy.
Brechbiel MW. Brechbiel MW. Cancer Biother Radiopharm. 2020 Aug;35(6):397. doi: 10.1089/cbr.2020.29008.mbr. Epub 2020 Jun 5. Cancer Biother Radiopharm. 2020. PMID: 32503377 No abstract available.
90Y-Daclizumab (Anti-CD25), High-Dose Carmustine, Etoposide, Cytarabine, and Melphalan Chemotherapy and Autologous Hematopoietic Stem Cell Transplant Yielded Sustained Complete Remissions in 4 Patients with Recurrent Hodgkin's Lymphoma.
Conlon KC, Sportes C, Brechbiel MW, Fowler DH, Gress R, Miljkovic MD, Chen CC, Whatley MA, Bryant BR, Corcoran EM, Kurdziel KA, Pittaluga S, Paik CH, Lee JH, Fleisher TA, Carrasquillo JA, Waldmann TA. Conlon KC, et al. Among authors: brechbiel mw. Cancer Biother Radiopharm. 2020 May;35(4):249-261. doi: 10.1089/cbr.2019.3298. Epub 2020 Apr 9. Cancer Biother Radiopharm. 2020. PMID: 32275165 Free PMC article. Clinical Trial.
Exploration of a F(ab')2 Fragment as the Targeting Agent of α-Radiation Therapy: A Comparison of the Therapeutic Benefit of Intraperitoneal and Intravenous Administered Radioimmunotherapy.
Milenic DE, Kim YS, Baidoo KE, Wong KJ, Barkley R, Delgado J, Brechbiel MW. Milenic DE, et al. Among authors: brechbiel mw. Cancer Biother Radiopharm. 2018 Jun;33(5):182-193. doi: 10.1089/cbr.2018.2434. Cancer Biother Radiopharm. 2018. PMID: 29916748 Free PMC article.
203 results